| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $594.4M | -5.0% |
| Cost of Revenue | $292.2M | +2.7% |
| Gross Profit | $302.2M | -11.5% |
| R&D Expense | $108.3M | +11.6% |
| SG&A Expense | $269.4M | +34.1% |
| Operating Income | -$194.7M | -661.5% |
| Interest Expense | $15.0M | +184.2% |
| Pre-tax Income | -$214.9M | -457.2% |
| Income Tax | $69.5M | +550.6% |
| Net Income | -$291.5M | -692.8% |
| EPS (Basic) | -$2.70 | -687.0% |
| EPS (Diluted) | -$2.70 | -758.5% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $294.3M | -34.1% |
| Accounts Receivable | $107.6M | -3.2% |
| Current Assets | $545.6M | -22.0% |
| Total Assets | $1.35B | -14.0% |
| Current Liabilities | $421.9M | -5.4% |
| Long-term Debt | $26.4M | — |
| Total Liabilities | $548.3M | +10.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$20.0M | -120.1% |
| Capital Expenditures | $1.6M | -28.9% |
| Investing Cash Flow | -$125.7M | -42.3% |
| Financing Cash Flow | -$6.7M | +46.7% |
| Free Cash Flow | -$21.6M | -122.2% |
| Stockholders' Equity |
| $804.0M |
| -25.2% |